[email protected]
CDI - Contrive Datum Insights
Agriculture

Nematicides MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy Mode of ActionBy Crop TypeBy Application MethodBy FormulationBy Target NematodeBy Cultivation SystemBy Farming PracticeBy Distribution ChannelBy End User

Full title & scope — all 10 axes with their segments

Nematicides Market Size, Share & Industry Analysis, By Product Type (Fumigants, Organophosphates and Carbamates, Novel Synthetic Chemistries, Microbial Biological Nematicides, Botanical and Natural Extracts), By Mode of Action (Contact, Systemic, Soil Fumigant Action, Biological Antagonism), By Crop Type (Fruits and Vegetables, Cereals and Grains, Oilseeds and Pulses, Turf and Ornamentals, Other Crops), By Application Method (Soil Treatment, Seed Treatment, Chemigation, Foliar Application), By Formulation (Liquid, Granular, Powder and Wettable Powder, Gas), By Target Nematode (Root-Knot Nematodes, Cyst Nematodes, Lesion Nematodes, Reniform Nematodes, Other Plant-Parasitic Nematodes), By Cultivation System (Open Field, Protected Cultivation, Orchards and Plantations), By Farming Practice (Conventional Farming, Organic Farming, Integrated Pest Management), By Distribution Channel (Direct Sales to Growers, Distributors and Agri-retailers, Cooperatives, Online Channels), By End User (Large Commercial Growers, Smallholder Farmers, Turf and Landscape Managers, Custom Applicators), and Regional Forecast, 2026-2034

Last Updated: Oct 30, 2026Format: PDFReport ID: CDI-248813
Summary

Market outlook, key takeaways, drivers and challenges for the report period.

Historical period
2020-2024
Base year
2025
Forecast period
2026-2034
CAGR
6.31%
Market size trend
20202025 base year2034
Global market size
2025 · baseUSD 2.4 Billion
2026USD 2.55 Billion
2034 · forecastUSD 4.16 Billion
Leading region, 2025
Asia Pacific · 36%
Leading region
Asia Pacific leads with 36% of global revenue through 2034
Segmentation
  1. 01By Product TypeFumigants · Organophosphates and Carbamates · Novel Synthetic Chemistries
  2. 02By Mode of ActionContact · Systemic · Soil Fumigant Action
  3. 03By Crop TypeFruits and Vegetables · Cereals and Grains · Oilseeds and Pulses
  4. 04By Application MethodSoil Treatment · Seed Treatment · Chemigation
  5. 05By FormulationLiquid · Granular · Powder and Wettable Powder
  6. 06By Target NematodeRoot-Knot Nematodes · Cyst Nematodes · Lesion Nematodes
  7. 07By Cultivation SystemOpen Field · Protected Cultivation · Orchards and Plantations
  8. 08By Farming PracticeConventional Farming · Organic Farming · Integrated Pest Management
  9. 09By Distribution ChannelDirect Sales to Growers · Distributors and Agri-retailers · Cooperatives
  10. 10By End UserLarge Commercial Growers · Smallholder Farmers · Turf and Landscape Managers
  11. 11By Region
Overview

Market Analysis & Outlook

Nematicides are crop protection products used to prevent or reduce damage from plant-parasitic nematodes, microscopic worms that feed on roots and cut yield and quality. The category covers chemical fumigants and non-fumigant chemistries, together with microbial and botanical products, sold as liquids, granules, powders and gases. Buyers are commercial growers of vegetables, fruit, field crops and turf, together with custom applicators and the distributors and cooperatives that supply them.

The global nematicides market is valued at USD 2.4 billion in 2025 and is set to reach USD 4.16 billion by 2034, a compound annual growth rate of 6.31% across the 2026-2034 forecast period. The study tracks the market across USD 1.92 billion in 2020, USD 2.29 billion in 2024, USD 2.55 billion in 2026 and USD 3.25 billion in 2030.

34% of 2025 revenue sits in Fumigants, worth USD 0.816 billion and rising to USD 1.165 billion at 28% by 2034, the largest product type line in both years. Growth is fastest in Microbial Biological Nematicides at 11.08% and slowest in Organophosphates and Carbamates at 0.43%. Novel Synthetic Chemistries, Microbial Biological Nematicides and Botanical and Natural Extracts take share over the period; Fumigants and Organophosphates and Carbamates give it up while still growing in absolute terms.

Cut by mode of action, the largest line is Soil Fumigant Action: 34% of 2025 revenue, worth USD 0.816 billion, and 27% at USD 1.123 billion by 2034. Biological Antagonism grows faster at 12.2% against 3.61%, moving from 16% of revenue to 26% by 2034. Both this axis and the product type one divide the same revenue, which is why they are alternative views, not components.

The regional order runs from Asia Pacific at 36% of 2025 revenue down to Middle East and Africa at 6%. Asia Pacific is worth USD 0.864 billion in 2025 and USD 1.677 billion in 2034; North America, second at 27%, moves from USD 0.648 billion to USD 1.019 billion. Because Asia Pacific and Latin America take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

The 2025 total is arrived at by triangulating published aggregates against category proxies, not by an independent count. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, five product type lines and ten segmentation axes across a fifteen-year window.

Market Size, 2020–2034

USD Billion
Base year 2025
USD 2.4 Billion
Forecast 2034
USD 4.2 Billion
CAGR 2025–2034
6.31%
ActualForecast
6
4.5
3
1.5
0
1.9
2
2.1
2.2
2.3
2.4
2.5
2.7
2.9
3.1
3.3
3.5
3.7
3.9
4.2
Forecast →
2020
2022
2024
2026
2028
2030
2032
2034

Revenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.

Analysis

Key Takeaways

  • The global nematicides market moves from USD 1.92 billion in 2020 to USD 2.4 billion in 2025 and USD 4.16 billion by 2034, the forecast period compounding at 6.31% a year.
  • The largest line by product type is Fumigants, worth USD 0.816 billion and 34% of revenue in 2025, rising to USD 1.165 billion and 28% by 2034.
  • Fastest growth on the product type axis belongs to Microbial Biological Nematicides: 11.08% a year, USD 0.336 billion to USD 0.874 billion, and a share moving from 14% to 21%.
  • Scenario range for 2034 runs from USD 3.5 billion in the bear case to USD 4.59 billion in the bull case, against a base-case USD 4.16 billion, the spread a plan built on this forecast has to absorb.
  • Asia Pacific holds 36% of global revenue in 2025 at USD 0.864 billion, the largest of the five regions tracked, and reaches USD 1.677 billion by 2034.
  • 34.72% of Asia Pacific's base-year revenue comes from China alone: USD 0.3 billion in 2025, rising to USD 0.6 billion by 2034, which is why it is that region's worked example.
  • The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and ten segmentation axes separately, with revenue, share and a growth rate for every line in each year.
Analysis

Revenue Share, By product type

Base year 2025

Fumigants leads with 34.0% of product type segment revenue.

34%
Fumigants
Fumigants
34.0%
Organophosphates and Carbamates
28.0%
Novel Synthetic Chemistries
17.0%
Microbial Biological Nematicides
14.0%
Botanical and Natural Extracts
7.0%

Share of product type segment revenue, most recent base year.

Three things move over 2026-2034, and they are worth separating: the product type mix, the regional balance, and the 6.31% compounding underneath both.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; what separates them is which takes the larger part of the growth.

Composition shifts on the product type axis. Microbial Biological Nematicides grows at 11.08% across 2026-2034 against 0.43% for Organophosphates and Carbamates, the widest spread on the product type axis. Microbial Biological Nematicides takes its share of revenue from 14% to 21% while Organophosphates and Carbamates gives up ground, from 28% to 17%. Revenue rises on both sides; USD 0.336 billion to USD 0.874 billion and USD 0.672 billion to USD 0.707 billion respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.

Growth concentrates in Asia Pacific and Latin America. Asia Pacific moves from 36% of revenue in 2025 to 40.3% in 2034, worth USD 0.864 billion rising to USD 1.677 billion; Latin America moves from 14% of revenue in 2025 to 14.5% in 2034, worth USD 0.336 billion rising to USD 0.603 billion. Against that, North America at 27% moving to 24.5%, Europe at 17% moving to 15.2%, Middle East and Africa at 6% moving to 5.5%, a fall in share, not in revenue. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.

Fifteen years without a discontinuity. The market moves through USD 1.92 billion in 2020, USD 2.29 billion in 2024, USD 2.4 billion in 2025, USD 2.55 billion in 2026, USD 3.25 billion in 2030 and USD 4.16 billion in 2034. The forecast rate of 6.31% sits against 4.56% over the historical period, so the projection extends an observed trend instead of proposing a new one. That moves the planning question away from timing a turn and onto the product type and regional mixes, where the actual movement is.

Analysis

Market Growth Factors

Microbial Biological Nematicides adds the most incremental growth

Market Drivers

3
  • 01
    Microbial Biological Nematicides adds the most incremental growth

    At 11.08% against a market rate of 6.31%, Microbial Biological Nematicides is the line pulling the average up: USD 0.336 billion to USD 0.874 billion, and 14% of revenue to 21%. Set against 0.43% at the other end of the axis, this is the line that decides whether the market's 6.31% holds. Exposure to this line, not to the market as a whole, is what determines a supplier's own rate.

  • 02
    Asia Pacific carries 36% of the base and keeps growing

    The largest regional base is Asia Pacific: USD 0.864 billion in 2025 at 36% of the global total, USD 1.677 billion by 2034 and 40.3%. North America adds a further 27% at USD 0.648 billion, reaching USD 1.019 billion. Most of the base and most of the growth sit in those two, and a plan spread evenly across regions therefore over-invests outside them.

  • 03
    A demonstrated trajectory, not a projected turnaround

    USD 1.92 billion in 2020, USD 2.29 billion in 2024 and USD 2.4 billion in 2025: 4.56% compound growth before the forecast period even begins. The forecast period then runs at 6.31%, ending 2034 at USD 4.16 billion. Fifteen years of unbroken growth in the series means the forecast rests on a demonstrated trajectory, not a projected turnaround, and it is why the 6.31% rate is applied flat across the whole period instead of ramped through it.

Growth drivers

#Growth driverImpactGross contribution (Billion)2026-282029-312032-34
1Rising nematode pressure in intensive vegetable, fruit and row crop productionHigh+0.7HighHighMedium
2Growth of biological nematicides and new registrationsMedium-High+0.55MediumHighHigh
3Shift to high-value crops and protected cultivationMedium+0.4MediumMediumMedium
4Wider use of seed treatment and precision applicationMedium+0.3MediumMediumMedium
5Crop protection intensification in emerging marketsMedium+0.22MediumMediumLow
6OthersLow+0.13LowLowLow
Total+2.3

Restraints

#RestraintImpactEstimated reduction (Billion)2026-282029-312032-34
1Regulatory withdrawal of older fumigants and organophosphatesHigh−0.28HighMediumMedium
2Price pressure from low-cost genericsMedium−0.14MediumMediumMedium
3Substitution by crop rotation and resistant varietiesMedium−0.12LowMediumMedium
Total−0.54

Drivers contribute 2.3 Billion and restraints remove 0.54 Billion, a net 1.76 Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.

Three sources account for the growth to 2034: 6.31% compounding across the base, share moving toward the faster product type lines, and above-market expansion in the leading regions.

Analysis

Restraining Factors

The bear case and what drives it

Market Restraints

2
  • 01
    The bear case and what drives it

    Fumigant and chemistry restrictions cut treated area faster than substitutes arrive, growers switch to rotation and resistant varieties, and low-cost generics hold prices down. On that assumption 2034 revenue lands at USD 3.5 billion against the USD 4.16 billion base case, from the same USD 2.4 billion 2025 starting point.

  • 02
    Fumigants holds the blended rate down

    Fumigants carries 34% of 2025 revenue at USD 0.816 billion but compounds at 4.02% against 6.31% for the market, taking its share to 28% by 2034 even as revenue rises to USD 1.165 billion. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.

Analysis

Market Opportunities

Where the forecast could be beaten

Market Opportunities

2
  • 01
    Where the forecast could be beaten

    The upside path assumes faster registration of new chemistries and biologicals, tighter limits on older products that push growers to pay for replacements, and wider nematode pressure lift treated area and realised prices. It ends 2034 at USD 4.59 billion against a USD 4.16 billion base case, off the same USD 2.4 billion base year.

  • 02
    The opening is on the product type axis, not the regional one

    Share on the product type axis moves toward Microbial Biological Nematicides, from 14% in 2025 to 21% in 2034, on 11.08% growth against the market's 6.31% and revenue rising from USD 0.336 billion to USD 0.874 billion. Taking position there does not require displacing whoever holds Fumigants, which is the harder and more expensive fight.

Analysis

Market Challenges

The total depends on a single line

Market Challenges

2
  • 01
    The total depends on a single line

    Fumigants is 34% of 2025 revenue at USD 0.816 billion and still 28% at USD 1.165 billion in 2034. No other single change on the product type axis moves the total as much as a change in demand for that one line.

  • 02
    Asia Pacific is largely China

    34.72% of the leading region is one country: China, at USD 0.3 billion against Asia Pacific's USD 0.864 billion in 2025, and USD 0.6 billion by 2034. The consequence is that regional risk here is really country risk wearing a larger label.

Structure

Segmentation Analysis

10 axes

ten segmentation axes are reported; by product type, by mode of action, crop type, application method, formulation, target nematode, cultivation system, farming practice, distribution channel and end user. Revenue does not add across them: each is a different cut of the same total.

All five product type lines expand in revenue terms over the forecast period. Share is the dividing line; three take it, the others cede it.

By Product Type · 5 segments

Microbial Biological Nematicides Outpaces the Axis While Fumigants Holds the Largest Share

  • Largest Fumigants · 34%
  • Fastest Microbial Biological Nematicides · 11.1%
  • Moves most Organophosphates and Carbamates · -11 pts
  • Order by 2034 changes
Segment2025Share2034ShareCAGR
Fumigants$0.82B34%$1.17B28%-64%
Organophosphates and Carbamates$0.67B28%$0.71B17%-110.4%
Novel Synthetic Chemistries$0.41B17%$1B24%+710.3%
Microbial Biological Nematicides$0.34B14%$0.87B21%+711.1%
Botanical and Natural Extracts$0.17B7%$0.42B10%+310.6%
Fumigants 28%Organophosphates and Carbamates 17%Novel Synthetic Chemistries 24%Microbial Biological Nematicides 21%Botanical and Natural Extracts 10%

Fumigants lead because they remain the established answer on high-value vegetable, fruit and nursery land, where nematode pressure is severe and soil treatment before planting is routine. Microbial biological products grow fastest as growers and retailers look for residue-friendly options while older chemistries lose registrations and new strains reach more crops and countries. By 2034 Fumigants is still ahead, making this a shift in weight, not a change of leader. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.

By Mode of Action · 4 segments

Soil Fumigant Action Led by Mode of action in 2025, with Biological Antagonism Growing Fastest

  • Largest Soil Fumigant Action · 34%
  • Fastest Biological Antagonism · 12.2%
  • Moves most Biological Antagonism · +10 pts
  • Order by 2034 changes
Segment2025Share2034ShareCAGR
Contact$0.58B24%$0.75B18%-63%
Systemic$0.62B26%$1.21B29%+37.6%
Soil Fumigant Action$0.82B34%$1.12B27%-73.6%
Biological Antagonism$0.38B16%$1.08B26%+1012.2%
Contact 18%Systemic 29%Soil Fumigant Action 27%Biological Antagonism 26%

Soil fumigant action leads because pre-plant fumigation gives the broadest and most predictable control through the soil profile in intensive vegetable and fruit production. Biological antagonism grows fastest as colonising microbes and bio-derived products enter integrated programmes, supported by easier registration pathways and retailer and processor pressure to cut chemical residues. Leadership changes hands: Systemic is the largest line by 2034, not Soil Fumigant Action.

By Crop Type · 5 segments

Oilseeds and Pulses Outpaces the Axis While Fruits and Vegetables Holds the Largest Share

  • Largest Fruits and Vegetables · 46%
  • Fastest Oilseeds and Pulses · 7.1%
  • Moves most Cereals and Grains · -2 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Fruits and Vegetables$1.10B46%$1.96B47%+16.5%
Cereals and Grains$0.48B20%$0.75B18%-25.1%
Oilseeds and Pulses$0.34B14%$0.62B15%+17.1%
Turf and Ornamentals$0.24B10%$0.42B10%6.3%
Other Crops$0.24B10%$0.42B10%6.3%
Fruits and Vegetables 47%Cereals and Grains 18%Oilseeds and Pulses 15%Turf and Ornamentals 10%Other Crops 10%

Fruits and vegetables lead because the crops are high in value per hectare, are grown intensively on repeat plantings and suffer the largest yield and quality losses from root damage. Oilseeds and pulses grow fastest as expanding acreage in warm regions brings soybean cyst and root-knot problems that growers now treat with seed-applied and in-furrow products. Fruits and Vegetables remains the largest line through 2034, so the axis changes in proportion, not in order.

By Application Method · 4 segments

Soil Treatment Held the Dominant Share of the Application method Segment in 2025

  • Largest Soil Treatment · 52%
  • Fastest Seed Treatment · 8.8%
  • Moves most Soil Treatment · -6 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Soil Treatment$1.25B52%$1.91B46%-64.9%
Seed Treatment$0.53B22%$1.12B27%+58.8%
Chemigation$0.34B14%$0.62B15%+17.1%
Foliar Application$0.29B12%$0.50B12%6.3%
Soil Treatment 46%Seed Treatment 27%Chemigation 15%Foliar Application 12%

Soil treatment leads because nematodes live in the root zone, and in-furrow, broadcast and pre-plant applications put the active ingredient where the damage occurs. Seed treatment grows fastest because it protects the young root with a small, low-labour dose, fits existing planter workflows and suits biological and low-volume chemistries that growers want to apply once. Soil Treatment remains the largest line through 2034, so the axis changes in proportion, not in order.

By Formulation · 4 segments

Scale and Growth Sit in the Same Line on the Formulation Axis: Liquid

  • Largest Liquid · 44%
  • Fastest Liquid · 7.3%
  • Moves most Liquid · +4 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Liquid$1.06B44%$2B48%+47.3%
Granular$0.62B26%$1.04B25%-15.8%
Powder and Wettable Powder$0.29B12%$0.46B11%-15.3%
Gas$0.43B18%$0.67B16%-24.9%
Liquid 48%Granular 25%Powder and Wettable Powder 11%Gas 16%

Liquid leads and grows fastest because it suits chemigation, in-furrow and seed treatment equipment, mixes with other inputs and carries biological actives that need controlled carriers. Gas formulations hold a large base in fumigation but face tighter buffer-zone and handling rules, while granules and powders lose ground to easier-to-apply liquids. Liquid remains the largest line through 2034, so the axis changes in proportion, not in order.

By Target Nematode · 5 segments

Scale and Growth Sit in the Same Line on the Target nematode Axis: Root-Knot Nematodes

  • Largest Root-Knot Nematodes · 48%
  • Fastest Root-Knot Nematodes · 6.5%
  • Moves most Root-Knot Nematodes · +1 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Root-Knot Nematodes$1.15B48%$2.04B49%+16.5%
Cyst Nematodes$0.38B16%$0.62B15%-15.5%
Lesion Nematodes$0.34B14%$0.58B14%6.3%
Reniform Nematodes$0.19B8%$0.33B8%6.3%
Other Plant-Parasitic Nematodes$0.34B14%$0.58B14%6.3%
Root-Knot Nematodes 49%Cyst Nematodes 15%Lesion Nematodes 14%Reniform Nematodes 8%Other Plant-Parasitic Nematodes 14%

Root-knot nematodes lead because they attack the widest range of vegetable, fruit and field crops and thrive in warm, sandy soils across the main growing regions. They also grow fastest as warming conditions and repeat cropping extend their range, and as growers move from occasional treatment to routine programmes that keep populations below damage thresholds. Root-Knot Nematodes remains the largest line through 2034, so the axis changes in proportion, not in order.

By Cultivation System · 3 segments

Open Field Led by Cultivation system in 2025, with Protected Cultivation Growing Fastest

  • Largest Open Field · 58%
  • Fastest Protected Cultivation · 8.1%
  • Moves most Open Field · -4 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Open Field$1.39B58%$2.25B54%-45.5%
Protected Cultivation$0.58B24%$1.17B28%+48.1%
Orchards and Plantations$0.43B18%$0.75B18%6.3%
Open Field 54%Protected Cultivation 28%Orchards and Plantations 18%

Open field leads because most treated area sits in field vegetables, row crops and turf. Protected cultivation grows fastest because greenhouse and tunnel growers crop the same soil season after season, which builds nematode populations quickly, and because their high returns per square metre justify the cost of repeated soil and drench treatments. By 2034 Open Field is still ahead, making this a shift in weight, not a change of leader.

By Farming Practice · 3 segments

Conventional Farming Led by Farming practice in 2025, with Organic Farming Growing Fastest

  • Largest Conventional Farming · 78%
  • Fastest Organic Farming · 10.1%
  • Moves most Conventional Farming · -8 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Conventional Farming$1.87B78%$2.91B70%-85%
Organic Farming$0.19B8%$0.46B11%+310.1%
Integrated Pest Management$0.34B14%$0.79B19%+510%
Conventional Farming 70%Organic Farming 11%Integrated Pest Management 19%

Conventional farming leads because it accounts for most treated acreage and relies on registered synthetic and fumigant products. Organic farming grows fastest from a small base as certified acreage expands and organic growers adopt approved botanical and microbial products, which are among the few nematode options permitted under organic standards. By 2034 Conventional Farming is still ahead, making this a shift in weight, not a change of leader.

By Distribution Channel · 4 segments

Online Channels Outpaces the Axis While Distributors and Agri-retailers Holds the Largest Share

  • Largest Distributors and Agri-retailers · 56%
  • Fastest Online Channels · 13.1%
  • Moves most Online Channels · +6 pts
  • Order by 2034 changes
Segment2025Share2034ShareCAGR
Direct Sales to Growers$0.53B22%$0.83B20%-25.2%
Distributors and Agri-retailers$1.34B56%$2.16B52%-45.4%
Cooperatives$0.34B14%$0.58B14%6.3%
Online Channels$0.19B8%$0.58B14%+613.1%
Direct Sales to Growers 20%Distributors and Agri-retailers 52%Cooperatives 14%Online Channels 14%

Distributors and agri-retailers lead because growers buy nematicides together with seed and other crop protection inputs and rely on local agronomists for product choice and timing. Online channels grow fastest from a small base as farm-input marketplaces and manufacturer portals extend reach to smaller growers who are poorly served by physical retail. By 2034 Distributors and Agri-retailers is still ahead, making this a shift in weight, not a change of leader.

By End User · 4 segments

Scale in Large Commercial Growers and Growth in Custom Applicators Define the End user Axis

  • Largest Large Commercial Growers · 44%
  • Fastest Custom Applicators · 7.7%
  • Moves most Smallholder Farmers · -3 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Large Commercial Growers$1.06B44%$1.91B46%+26.8%
Smallholder Farmers$0.72B30%$1.12B27%-35.1%
Turf and Landscape Managers$0.24B10%$0.37B9%-15%
Custom Applicators$0.38B16%$0.75B18%+27.7%
Large Commercial Growers 46%Smallholder Farmers 27%Turf and Landscape Managers 9%Custom Applicators 18%

Large commercial growers lead because they farm the high-value, intensively managed land where nematode losses justify the spend. Custom applicators grow fastest because fumigation and restricted-use products need licensed equipment and trained staff, so growers increasingly outsource application instead of carrying the compliance burden themselves. By 2034 Large Commercial Growers is still ahead, making this a shift in weight, not a change of leader.

Analysis

Regional Insights

Regional Revenue Share

Base year 2025
36%
Asia Pacific
Leading region
36%Asia Pacific

Share of global revenue in the base year.

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Only the leading region's share is published outside the report; pins mark the region, not a specific country.

Leading Region
Asia Pacific leads with 36% of global revenue through 2034

North America Market Analysis

The 2nd-largest region covered — 2.5 points of share move elsewhere by 2034.

  • Rank 2 of 5
  • 2025 share 27%
  • By 2034 24.5%
  • Revenue $0.65B → $1.02B

North America holds 27% of the global nematicides market in 2025, worth USD 0.648 billion rising to USD 1.019 billion in 2034. By revenue it sits second across the study, and the ranking does not change between 2025 and 2034.

Share settles at 24.5% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

Segment composition follows the global pattern: Fumigants largest at 34% of 2025 revenue, Microbial Biological Nematicides fastest at 11.08%. The full report breaks North America out along every axis and by country.

United States

Sets the pace for North America at 78.7% of it, growing 1.6×.

  • In region 1 of 3
  • Of region 78.7%
  • Of global 21.3%
  • Revenue $0.51B → $0.80B

78.7% of North America's base-year revenue comes from the United States; USD 0.51 billion, rising to USD 0.8 billion by 2034. Because it is 78.7% of the region in the base year, North America's totals move with this one country instead of a spread of them. Set against USD 0.648 billion and USD 1.019 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

the United States buys along the same lines as the market globally; Fumigants first at 34% of 2025 revenue and 28% in 2034, Microbial Biological Nematicides fastest at 11.08% on a share moving from 14% to 21%. Its 78.7% weight in North America means those movements carry straight into the regional totals. Revenue by product type for the United States is reported separately in the full report.

Nematicides in the United States are pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act, administered by the Environmental Protection Agency. A product must be registered before sale, supported by data on efficacy, human health, ecological effects and environmental fate. Active ingredients are reviewed periodically under registration review, and some products are classified as restricted use, limiting purchase and application to certified applicators. The label is a legal document: the registrant must follow its directions on rates, crops, worker protection and buffer zones. States run their own registration step on top of the federal one, and California applies the most demanding additional review.

Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd. are the suppliers covered in the United States. Volume sits in Fumigants at 34% of 2025 revenue; movement sits in Microbial Biological Nematicides at 11.08% growth. Country-level positioning and shares for each of these companies are part of the full report, not of this summary.

Canada

2nd-largest in North America, growing 1.6×.

  • In region 2 of 3
  • Of region 10.8%
  • Of global 2.9%
  • Revenue $0.07B → $0.11B

Within North America, Canada accounts for 10.8% of regional revenue and 2.92% of the global total, worth USD 0.07 billion in 2025 and USD 0.11 billion by 2034.

Mexico

3rd-largest in North America, growing 1.6×.

  • In region 3 of 3
  • Of region 8.9%
  • Of global 2.4%
  • Revenue $0.06B → $0.10B

Mexico is sized at USD 0.058 billion in 2025, rising to USD 0.095 billion by 2034; 2.42% of global revenue and 8.95% of North America. It is reported separately from the United States across every segmentation axis in the full report.

Europe Market Analysis

The 3rd-largest region covered — 1.8 points of share move elsewhere by 2034.

  • Rank 3 of 5
  • 2025 share 17%
  • By 2034 15.2%
  • Revenue $0.41B → $0.63B

17% of the global nematicides market sits in Europe in 2025, worth USD 0.408 billion rising to USD 0.632 billion in 2034. It is a mid-sized region on this axis, third by revenue throughout the period.

By 2034 the share stands at 15.2%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

The product type mix reported at global level applies here, with Fumigants the largest line at 34% of 2025 revenue and Microbial Biological Nematicides the fastest-growing at 11.08%. The full report breaks Europe out along every axis and by country.

France

The largest market in Europe, growing 1.5×.

  • In region 1 of 3
  • Of region 18.4%
  • Of global 3.1%
  • Revenue $0.07B → $0.11B

The largest single market in Europe is France, at USD 0.075 billion in 2025 and USD 0.11 billion in 2034. It accounts for 18.38% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 0.408 billion in 2025 and USD 0.632 billion in 2034, it is the country the full report breaks out in detail.

Demand in France follows the product type mix reported at global level: Fumigants is the largest line at 34% of 2025 revenue, moving to 28% by 2034, while Microbial Biological Nematicides grows fastest at 11.08% and takes its share from 14% to 21%. Its 18.38% weight in Europe means those movements carry straight into the regional totals. France carries its own product type breakdown in the full report.

In France, nematicides are plant protection products governed by the European Union framework, under which active substances are approved at EU level and the products containing them are authorised nationally. The national authority is ANSES, which evaluates and grants market authorisation after assessing efficacy, toxicology and environmental risk. Classification and labelling follow the EU CLP Regulation, and use is bound by the sustainable use directive, including training and certification for professional users. Many older soil fumigant and carbamate nematicide actives have been withdrawn from the EU list, so the authorised range is narrow and dossiers must show a clear case for approval.

Competition in France runs between the suppliers this study tracks: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Fumigants, at 34% of 2025 revenue, is where the volume sits, and Microbial Biological Nematicides, growing at 11.08%, is where position changes hands over the forecast period. A supplier weighted toward Europe is competing over a base of USD 0.408 billion in 2025 reaching USD 0.632 billion by 2034, 17% of global revenue at the start of that period.

Spain

2nd-largest in Europe, growing 1.5×.

  • In region 2 of 3
  • Of region 15.9%
  • Of global 2.7%
  • Revenue $0.07B → $0.10B

Spain is sized at USD 0.065 billion in 2025, rising to USD 0.1 billion by 2034; 2.71% of global revenue and 15.93% of Europe. It is reported separately from France across every segmentation axis in the full report.

Italy

3rd-largest in Europe, growing 1.5×.

  • In region 3 of 3
  • Of region 14.7%
  • Of global 2.5%
  • Revenue $0.06B → $0.09B

Within Europe, Italy accounts for 14.71% of regional revenue and 2.5% of the global total, worth USD 0.06 billion in 2025 and USD 0.09 billion by 2034.

Asia Pacific Market Analysis

The largest region covered, and the one gaining the most — it picks up 4.3 points of share by 2034, while revenue still grows 1.9×.

  • Rank 1 of 5
  • 2025 share 36%
  • By 2034 40.3%
  • Revenue $0.86B → $1.68B

In Asia Pacific, 36% of global revenue puts 2025 at USD 0.864 billion rising to USD 1.677 billion in 2034. That makes it the first-largest region covered, in 2025 and again in 2034.

Share climbs to 40.3% by 2034, because it outgrows the market's 6.31%; the revenue added here is disproportionate to where the region started.

Within the region the product type split tracks the global one; 34% of 2025 revenue in Fumigants, fastest growth of 11.08% in Microbial Biological Nematicides. The full report breaks Asia Pacific out along every axis and by country.

China

The largest market in Asia Pacific, growing 2.0×.

  • In region 1 of 3
  • Of region 34.7%
  • Of global 12.5%
  • Revenue $0.30B → $0.60B

The largest single market in Asia Pacific is China, at USD 0.3 billion in 2025 and USD 0.6 billion in 2034. It accounts for 34.72% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 0.864 billion to USD 1.677 billion over the same period, and this is the market carrying the country-level detail in the full report.

Demand in China follows the product type mix reported at global level: Fumigants is the largest line at 34% of 2025 revenue, moving to 28% by 2034, while Microbial Biological Nematicides grows fastest at 11.08% and takes its share from 14% to 21%. With 34.72% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by product type for China is reported separately in the full report.

Pesticide registration in China is administered by the Institute for the Control of Agrochemicals under the Ministry of Agriculture and Rural Affairs. A supplier must obtain a registration certificate before manufacture or import, submitting dossiers on chemistry, efficacy trials conducted in the country, toxicology and environmental behaviour. Foreign companies generally need a local entity or agent to hold the registration. Separate licences cover production, and a further business licence is required for distribution. Labels must carry the registration number, toxicity class, active ingredient content and usage directions in Chinese, and highly toxic actives face restrictions or bans.

In China the field is Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 34% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 11.08%. The commercial size of that position is USD 0.864 billion in 2025, moving to USD 1.677 billion by 2034 across the forecast period.

India

2nd-largest in Asia Pacific, growing 2.2×.

  • In region 2 of 3
  • Of region 17.4%
  • Of global 6.3%
  • Revenue $0.15B → $0.33B

India is sized at USD 0.15 billion in 2025, rising to USD 0.33 billion by 2034; 6.25% of global revenue and 17.36% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

Japan

3rd-largest in Asia Pacific, growing 1.4×.

  • In region 3 of 3
  • Of region 11%
  • Of global 4%
  • Revenue $0.10B → $0.13B

Japan is sized at USD 0.095 billion in 2025, rising to USD 0.13 billion by 2034; 3.96% of global revenue and 11% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

Latin America Market Analysis

The 4th-largest region covered — it picks up 0.5 points of share by 2034, while revenue still grows 1.8×.

  • Rank 4 of 5
  • 2025 share 14%
  • By 2034 14.5%
  • Revenue $0.34B → $0.60B

In Latin America, 14% of global revenue puts 2025 at USD 0.336 billion and reaches USD 0.603 billion by 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.

Its share rises to 14.5% over the forecast period, so the region grows faster than the market's 6.31% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

Within the region the product type split tracks the global one; 34% of 2025 revenue in Fumigants, fastest growth of 11.08% in Microbial Biological Nematicides. Latin America is reported axis by axis and country by country in the full study.

Brazil

The largest market in Latin America, growing 1.8×.

  • In region 1 of 2
  • Of region 49.1%
  • Of global 6.9%
  • Revenue $0.17B → $0.30B

The largest single market in Latin America is Brazil, at USD 0.165 billion in 2025 and USD 0.3 billion in 2034. Its 49.11% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. The region itself runs USD 0.336 billion to USD 0.603 billion over the same period, and this is the market carrying the country-level detail in the full report.

Brazil buys along the same lines as the market globally; Fumigants first at 34% of 2025 revenue and 28% in 2034, Microbial Biological Nematicides fastest at 11.08% on a share moving from 14% to 21%. Since 49.11% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Brazil carries its own product type breakdown in the full report.

Brazil divides pesticide oversight among three bodies: the Ministry of Agriculture, which holds the registration decision; the health regulator ANVISA, which assesses toxicological risk; and the environmental agency IBAMA, which assesses environmental hazard. The pesticide law sets out the registration route, and a nematicide must pass all three assessments before it can be sold. Products are classified by toxicological and environmental category, and labels and leaflets must show that classification with pictograms and use directions. Sale requires an agronomic prescription issued by a qualified professional, and state-level registration of the distributor is also expected.

Competition in Brazil runs between the suppliers this study tracks: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 34% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 11.08%. The commercial size of that position is USD 0.336 billion in 2025, moving to USD 0.603 billion by 2034 across the forecast period.

Argentina

2nd-largest in Latin America, growing 1.8×.

  • In region 2 of 2
  • Of region 11.9%
  • Of global 1.7%
  • Revenue $0.04B → $0.07B

1.67% of global revenue is generated in Argentina; USD 0.04 billion in 2025, reaching USD 0.07 billion in 2034, and 11.9% of Latin America.

Middle East and Africa Market Analysis

The 5th-largest region covered — 0.5 points of share move elsewhere by 2034.

  • Rank 5 of 5
  • 2025 share 6%
  • By 2034 5.5%
  • Revenue $0.14B → $0.23B

6% of the global nematicides market sits in Middle East and Africa in 2025, worth USD 0.144 billion on the way to USD 0.229 billion by 2034. That makes it the fifth-largest region covered, in 2025 and again in 2034.

Share settles at 5.5% in 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

The product type mix reported at global level applies here, with Fumigants the largest line at 34% of 2025 revenue and Microbial Biological Nematicides the fastest-growing at 11.08%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

South Africa

The largest market in Middle East and Africa, growing 1.6×.

  • In region 1 of 2
  • Of region 20.8%
  • Of global 1.3%
  • Revenue $0.03B → $0.05B

South Africa is the largest market within Middle East and Africa, generating USD 0.03 billion in 2025 and projected to reach USD 0.048 billion by 2034. At 20.83% of the region in 2025 it leads, but a majority of Middle East and Africa's revenue is generated in other markets. Set against USD 0.144 billion and USD 0.229 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

The product type pattern in South Africa is the global one: 34% of 2025 revenue in Fumigants, 28% by 2034, against 11.08% growth in Microbial Biological Nematicides taking it from 14% to 21%. With 20.83% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Per-product type revenue for South Africa appears on its own in the full report.

Nematicides in South Africa fall under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, administered by the Department of Agriculture through the Registrar of the Act. An agricultural remedy must be registered before it can be imported, sold or used, with data on efficacy, residues, toxicology and environmental effects. Registered products are labelled with the registration number, directions for use, warnings and the hazard class, following the national classification aligned with the Globally Harmonized System. Pest control product practitioners and sellers must also be registered, and use on export crops is shaped by the maximum residue limits of destination markets.

In South Africa the field is Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 34% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 11.08%. A supplier weighted toward Middle East and Africa is competing over a base of USD 0.144 billion in 2025 reaching USD 0.229 billion by 2034, 6% of global revenue at the start of that period.

Egypt

2nd-largest in Middle East and Africa, growing 1.6×.

  • In region 2 of 2
  • Of region 15.3%
  • Of global 0.9%
  • Revenue $0.02B → $0.04B

Egypt is sized at USD 0.022 billion in 2025, rising to USD 0.036 billion by 2034; 0.92% of global revenue and 15.28% of Middle East and Africa. It is reported separately from South Africa across every segmentation axis in the full report.

Download a free sample to see the full data tables and segment-level detail behind this analysis.

Analysis

Report Coverage

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by product type, mode of action, crop type, application method, formulation, target nematode, cultivation system, farming practice, distribution channel, end user, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.

Competition

Competitive Landscape

Scale in Fumigants and Growth in Microbial Biological Nematicides Set the Terms of Competition

Suppliers in scope: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd..

Competition follows the product type split, not the regional one. Volume sits in Fumigants, USD 0.816 billion and 34% of 2025 revenue, 28% by 2034, which is also where an incumbent is hardest to dislodge. Share moves in Microbial Biological Nematicides, growing 11.08% against 0.43% for Organophosphates and Carbamates. The two rarely sit with the same supplier, and that is the reason a USD 2.4 billion market is not already consolidated.

Suppliers separate on registration breadth, formulation and manufacturing scale, and access to growers. The largest players hold broad active ingredient portfolios, global regulatory teams that can carry a product through many approvals, and distributor relationships that place products on the shelf next to seed and other crop protection inputs. They can also bundle nematicides with seed treatment and fungicide programmes. Smaller and regional suppliers compete on generic and off-patent actives, local price, specialist biological strains, and responsive technical support for particular crops. Supply reliability for fumigant gases and the speed of launching new biological products also decide who wins repeat orders.

Geographic reach is the other axis of competition. Asia Pacific alone accounts for 36% of 2025 revenue, so a supplier absent there is absent from the largest part of the market whatever its position elsewhere; North America adds a further 27%.

Per-company profiles, financials, share and development history are in the full report and not here.

List of Key Nematicides Market Companies Profiled

30 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.

  • Bayer AG(Germany)
  • Syngenta Group(Switzerland)
  • Corteva Agriscience(United States)
  • BASF SE(Germany)
  • FMC Corporation(United States)
  • UPL Limited(India)
  • Adama Ltd.(Israel)
  • Nufarm Limited(Australia)
  • Sumitomo Chemical Co., Ltd.(Japan)
  • Albaugh LLC(United States)
  • American Vanguard Corporation(United States)
  • Certis Biologicals(United States)
  • Marrone Bio Innovations (Bioceres Crop Solutions)(United States)
  • Bioceres Crop Solutions Inc.(Argentina)
  • Novozymes (Novonesis)(Denmark)
  • Koppert Biological Systems(Netherlands)
  • Rovensa Next
  • Lallemand Inc.(Canada)
  • Isagro S.p.A. (Gowan Company)(Italy)
  • Arysta LifeScience (UPL)
  • Sipcam Oxon S.p.A.(Italy)
  • Rallis India Limited(India)
  • Hebei Veyong Pharmaceutical Co., Ltd.(China)
  • Shandong Weifang Rainbow Chemical Co., Ltd.(China)
  • Lier Chemical Co., Ltd.(China)
  • Pasteuria Bioscience (Syngenta)(United States)
  • Eastman Chemical Company(United States)
  • TriCal Inc.(United States)
  • Nichino America, Inc.(United States)
  • Ishihara Sangyo Kaisha, Ltd.(Japan)
Coverage

Geographic Coverage

5 regions · 30 markets

Every market below is broken out separately in the report.

North America

3
USCanadaMexico

Europe

8
GermanyFranceItalySpainUKNordic CountriesBenelux UnionRest of Europe

Asia Pacific

12
IndiaAustraliaChinaChina (Taiwan)JapanSouth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporeRest of Asia Pacific

Latin America

3
BrazilArgentinaRest of Latin America

Middle East and Africa

4
GCCEgyptSouth AfricaRest of the Middle East & Africa
At a glance

Key Insights

5
Regions covered
Including North America, Europe, Asia Pacific.
30
Companies profiled
Leading companies active in this market.
2025
Base year
Verified base-year data underpins every estimate.
2020–2034
Study period
Historical actuals plus the full forecast horizon.
Parameters

Report Scope

Study parameters & segmentation

This study covers market size and forecasts over the 2020–2034 period, segmentation across 10 axes (Product Type, Mode of Action, Crop Type, Application Method, Formulation, Target Nematode, Cultivation System, Farming Practice, Distribution Channel, End User), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 30 key companies, and the research methodology behind every estimate.

Study period
2020–2034
Base year
2025
Estimated year
2026
Historical period
2020-2024
Forecast period
2026-2034
Growth rate
6.31% CAGR
Unit
USD Billion

Segmentation

10 axes + region
By Product Type
FumigantsOrganophosphates and CarbamatesNovel Synthetic ChemistriesMicrobial Biological NematicidesBotanical and Natural Extracts
By Mode of Action
ContactSystemicSoil Fumigant ActionBiological Antagonism
By Crop Type
Fruits and VegetablesCereals and GrainsOilseeds and PulsesTurf and OrnamentalsOther Crops
By Application Method
Soil TreatmentSeed TreatmentChemigationFoliar Application
By Formulation
LiquidGranularPowder and Wettable PowderGas
By Target Nematode
Root-Knot NematodesCyst NematodesLesion NematodesReniform NematodesOther Plant-Parasitic Nematodes
By Cultivation System
Open FieldProtected CultivationOrchards and Plantations
By Farming Practice
Conventional FarmingOrganic FarmingIntegrated Pest Management
By Distribution Channel
Direct Sales to GrowersDistributors and Agri-retailersCooperativesOnline Channels
By End User
Large Commercial GrowersSmallholder FarmersTurf and Landscape ManagersCustom Applicators
By Geography
North America: US, Canada, Mexico
Europe: Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe
Asia Pacific: India, Australia, China, China (Taiwan), Japan, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East and Africa: GCC, Egypt, South Africa, Rest of the Middle East & Africa
Backed by primary research into key growth drivers, competitive dynamics, and regional demand shifts. Full analysis is available in the sample report.
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Nematicides Market projected to reach?

USD 4.16 Billion by 2034, CAGR 6.31%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

Asia Pacific leads with 36% of global revenue through 2034.

05Which segment leads the market?

Fumigants is the largest line by product type, at 34% of revenue in 2025.

06Who are the key companies profiled?

Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc., Ishihara Sangyo Kaisha, Ltd.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.